Ideal Potency of Edible Products 5MGs of THC or Less, Organigram Consumer Research Survey Concludes
March 10 2020 - 6:00AM
Business Wire
- Survey canvased over 2,000 Canadians on perceptions and
attitudes around edible products
- Results reveal top concerns that may impact purchase decisions,
including controlling dosage, tested products and reliable
onset/offset time
- Data to inform Company’s product design and educational
programming
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent
company of Organigram Inc. (the “Company” or “Organigram”), a
leading licensed producer of cannabis, has released summary
findings gathered in a research project designed to learn more
about Canadians’ perceptions and attitudes around cannabis edible
products.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20200310005190/en/
(Graphic: Business Wire)
The survey, conducted through the fall of 2019, queried
Canadians in every province on their anticipated consumption habits
following the release of ‘Cannabis 2.0’ products, and their primary
wants and needs in edible products. Results revealed that
Canadians’ ideal dosage for edible products is 5 mg of THC or less
per serving.
“Legalization has changed the way people think about cannabis
consumption. Entering this new era of cannabis legalization and
designing new product types, we couldn’t assume to know Canadians’
attitudes on edibles, so we asked them,” said Greg Engel, CEO,
Organigram. “We learned a few important insights around dosage, and
how and where Canadians may consume edibles, and moreover, what
product attributes were important to them. We knew generally that
many were looking forward to the availability of edible products,
but we wanted to be well-informed in our approach so we could
deliver thoughtfully designed infused edible products.”
A population-representative sample of 2,001 Canadians was used
in the survey, proportionately capturing men and women, in all
provinces and adult age groups, both current and non-users of
cannabis.
Insights from the survey include:
- About half of current non-consumers of cannabis would feel
confident to purchase and try edible products, if provided
information around ingredients, potency and effect. - Ideal potency
of edible products tends to be low, at 5 mg of THC per serving, or
less. - Most types of edibles are expected to be consumed in
private settings, either at home or private parties. - Chocolates,
baked goods and sweets are among the most sought-after edible
formats. - Over half of current cannabis consumers anticipate
choosing edibles over alcohol some of the time, now that edibles
are available in the legal market. - The most important
considerations in choosing to consume edible products include:
- Controlling the dose
- Regulated, tested products
- Reliable onset/offset time
- Effectiveness
- Taste
“These insights will not only help our product teams make
informed decisions around product design but will help us
understand what Canadians need to know most. With this information,
we can build thoughtful consumer resource materials around a number
of crucial topics, including the importance of consistent dosage
and transparency of composition of cannabis products to help
consumers make empowered, informed purchase decisions.”
The Company shipped the first units of its Edison Cannabis
Co.-branded Bytes chocolate truffles to jurisdictional partners
across Canada in February. The Company’s first prepared edible
product for adult-use consumers, Bytes mark the first edible
release in the Company’s rollout plans for premium infused
chocolate products across Edison Cannabis Co. and Trailblazer
brands.
A high-resolution data-summary infographic is available to media
upon request.
About Organigram Holdings Inc.
Organigram Holdings Inc. is a NASDAQ Global Select and TSX
listed company whose wholly owned subsidiary, Organigram Inc., is a
licensed producer of cannabis and cannabis-derived products in
Canada.
Organigram is focused on producing high-quality, indoor-grown
cannabis for patients and adult recreational consumers in Canada,
as well as developing international business partnerships to extend
the Company's global footprint. Organigram has also developed a
portfolio of legal adult use recreational cannabis brands including
The Edison Cannabis Company, Ankr Organics and Trailblazer.
Organigram's primary facility is located in Moncton, New Brunswick
and the Company is regulated by the Cannabis Act and the Cannabis
Regulations (Canada).
This news release contains forward-looking information. Often,
but not always, forward-looking information can be identified by
the use of words such as “plans”, “expects”, “estimates”,
“intends”, “anticipates”, “believes” or variations of such words
and phrases or state that certain actions, events, or results
“may”, “could”, “would”, “might” or “will” be taken, occur or be
achieved. Forward-looking information involves known and unknown
risks, uncertainties and other factors that may cause actual
results, events, performance or achievements of Organigram to
differ materially from current expectations or future results,
performance or achievements expressed or implied by the
forward-looking information contained in this news release. Risks,
uncertainties and other factors involved with forward-looking
information could cause actual events, results, performance,
prospects and opportunities to differ materially from those
expressed or implied by such forward-looking information include
risks as disclosed in the Company’s most recent annual information
form, management’s discussion and analysis and other Company
documents filed from time to time on SEDAR (see www.sedar.com) and
filed or furnished to the Securities and Exchange Commission on
EDGAR (see www.sec.gov). Readers are cautioned not to place undue
reliance on these forward-looking statements, which speak only as
of the date of this press release. Although the Company believes
that the assumptions and factors used in preparing the
forward-looking information in this news release are reasonable,
undue reliance should not be placed on such information and no
assurance can be given that such events will occur in the disclosed
time frames or at all. The forward-looking information included in
this news release are made as of the date of this news release and
the Company disclaims any intention or obligation, except to the
extent required by law, to update or revise any forward-looking
information, whether as a result of new information, future events
or otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200310005190/en/
For Investor relations enquiries, please contact: Amy Schwalm
Vice President, Investor Relations Amy.Schwalm@organigram.ca (416)
704-9057
For Media enquiries, please contact: Ray Gracewood Senior Vice
President, Marketing and Communications ray.gracewood@organigram.ca
(506) 645-1653
Organigram (NASDAQ:OGI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Organigram (NASDAQ:OGI)
Historical Stock Chart
From Apr 2023 to Apr 2024